Tarnished Image, Tighter Budgets Stymie Academic Science As School Year Begins

Still reeling from recent bouts of bad P.R., and in a bind for funding, some schools are reassessing their research missions As the academic year begins, university executives, research administrators, and others are reviewing with considerable trepidation a deskload of headaches affecting their 1991-1992 research agendas. There are stacks of articles about university misconduct and fraud from major newspapers and magazines, accounting ledgers revealing budgetary shortfalls, and memos from di

Written byRobin Eisner
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

As the academic year begins, university executives, research administrators, and others are reviewing with considerable trepidation a deskload of headaches affecting their 1991-1992 research agendas.

There are stacks of articles about university misconduct and fraud from major newspapers and magazines, accounting ledgers revealing budgetary shortfalls, and memos from disgruntled science faculty complaining about competition for tight research dollars. University scientists themselves are coming back to piles of grant applications they will meticulously fill out with little guarantee of success.

How will this blend of fiscal pressure and bad P.R. ultimately impact academic research? Some administrators interviewed for this article say that the difficulties will not trickle down to the faculty. The problems, they say, can be handled at the administrative level; indeed, they go so far as to say that the size of university administration was bloated, anyway, and needed some restraint. Others, however, wonder what will happen next year ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies